Literature DB >> 2053906

Accuracy of oxyhemoglobin saturation monitors during simulated altitude exposure of men with chronic obstructive pulmonary disease.

W J Mehm1, T A Dillard, B W Berg, J W Dooley, K R Rajagopal.   

Abstract

Patients with chronic obstructive pulmonary disease (COPD) are at risk for hypoxemia during air travel. We assessed the comparative performance of oxyhemoglobin saturation (%O2Hb) monitors on these patients during hypobaric exposure. We measured %O2Hb by arterial catheter blood co-oximetry (COOX) and compared these values to those from a transmittance ear oximeter and a reusable digital pulse oximeter. Additionally, we examined the effect of oxygen supplementation (4 L/min) on %O2Hb. A total of 18 ambulatory males with severe COPD were exposed to 8,000 ft (565 mm Hg) in a hypobaric chamber. Multiple measures of %O2Hb were made with each monitor at sea level and at 8,000 ft, with and without supplemental oxygen. By COOX, %O2Hb fell at altitude to clinically significant levels, and was subsequently corrected with supplemental oxygen. Saturations measured by the transmittance ear oximeter were very close to the COOX, underestimating the true value by only 0.6% at altitude (p less than 0.05), while the reusable digital pulse oximeter over-estimated %O2Hb alinearly by a mean of 3.8% at altitude.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2053906

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  2 in total

Review 1.  [Air travel and respiratory diseases].

Authors:  Francisco García Río; Luis Borderías Clau; Ciro Casanova Macario; Bartolomé R Celli; Joan Escarrabill Sanglás; Nicolás González Mangado; Josep Roca Torrent; Fernando Uresandi Romero
Journal:  Arch Bronconeumol       Date:  2007-02       Impact factor: 4.872

Review 2.  Prevention of Medical Events During Air Travel: A Narrative Review.

Authors:  Diane Naouri; Frederic Lapostolle; Claire Rondet; Olivier Ganansia; Dominique Pateron; Youri Yordanov
Journal:  Am J Med       Date:  2016-06-04       Impact factor: 4.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.